CN Patent

CN110327338A — 包含安非他酮或相关化合物和右美沙芬的组合物和方法

Assigned to Antecip Bioventures II LLC · Expires 2019-10-15 · 7y expired

What this patent protects

本公开涉及包含安非他酮或相关化合物和右美沙芬的组合物和方法。本公开涉及通过将抗抑郁剂化合物和右美沙芬向有此需要的人施用来治疗神经病症的方法。该方法可用于右美沙芬快代谢者的人。还描述了包含抗抑郁剂化合物和右美沙芬的组合物、药物和剂型。

USPTO Abstract

本公开涉及包含安非他酮或相关化合物和右美沙芬的组合物和方法。本公开涉及通过将抗抑郁剂化合物和右美沙芬向有此需要的人施用来治疗神经病症的方法。该方法可用于右美沙芬快代谢者的人。还描述了包含抗抑郁剂化合物和右美沙芬的组合物、药物和剂型。

Drugs covered by this patent

Patent Metadata

Patent number: CN110327338A
Jurisdiction: CN
Classification: —
Expires: 2019-10-15
Drug substance claim: No
Drug product claim: No
Assignee: Antecip Bioventures II LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.